Skip to main content

"Vi har registreret, at du besøger siden fra {0}. Vil du skifte sprog for at se indhold, der er tilpasset dig?"

->

3M Prevena Therapy for orthopaedic surgery

Advancing the standard of care in orthopaedic surgery

Orthopaedic surgery patient care extends beyond the operating room (OR). While confidence in the OR is essential, postoperative concerns like infections, swelling, and tissue integration can impact recovery. 3M™ Prevena™ Therapy provides you with a proactive strategy for incision care, elevating the standard of postoperative treatment and optimising the healing environment to enhance your patients' recovery experience.

Knee incision with 3M™ Prevena Restor™ Arthro Form™ Dressing applied. MedPeople_OR_11967
Impact of Prevena Therapy Proactive Risk Management Videos Resources
På denne side...
Impact of Prevena Therapy
Proactive Risk Management
Videos
Resources

Enhanced orthopaedic surgery outcomes with Prevena Therapy

A peer-reviewed meta-analysis of 12 studies for orthopaedic joint replacement procedures demonstrated Prevena Therapy helped significantly reduce the risk of various surgical site complications (SSCs) while helping to improve health economic outcomes compared to standard-of-care dressings.¹

Icon illustration 67%
Reduction in SSCs¹,*

8 studies; p<0.001†

Icon illustration 61%
Reduction in surgical site infections (SSIs)¹,*

7 studies; p=0.016†

Icon illustration 53%
Reduction in seromas¹,*

3 studies; p=0.008†

*Relative risk reduction based on risk ratios reported in this study.

†Calculation(s) are derived based on the relative patient group incidence rate reporting in this study. Statistically significant (p<0.05).

 

 See full indications for use and limitations at hcbgregulatory.3M.com.

Prevena Therapy videoressourcer

Prevena Therapy video resources

Explore more

Abstracts

Discover abstracts from prominent research papers on topics related to Prevena Therapy, offering valuable scientific findings and perspectives.

Kontakt en Solventum-repræsentant

Vi er her for at hjælpe! Vores team af repræsentanter kan give dig information og ressourcer, der kan hjælpe dig. Udfyld formularen nedenfor for at tale med en Solventum-repræsentant og lære mere om dine muligheder.

Leder du efter kundesupport? Besøg kundesupportsiden.

Felter markeret med en * er påkrævet.

 

Solventum vil bruge oplysningerne til at besvare din anmodning i overensstemmelse med vores Privatlivspolitik. 

Kontakt en Solventum-repræsentant

Vi er her for at hjælpe! Vores team af repræsentanter kan give dig information og ressourcer til at hjælpe dig. Indsend formularen nedenfor for at tale med en Solventum-repræsentant for at lære mere om dine muligheder.

Leder du efter kundesupport? Besøg siden med kundesupport.

Felter markeret med * er obligatoriske.

Venligst indtast en arbejds-e-mailadresse

 

Solventum vil bruge oplysningerne til at svare på din anmodning og i overensstemmelse med vores politik om beskyttelse af personlige oplysninger.

Vi beklager. Der opstod en fejl under indsendelsen. Prøv igen senere

There was an error processing your request. Please try again later.

NOTE:


Specific indications, limitations, contraindications, warnings, precautions and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. This material is intended for healthcare professionals.

The 3M™ Prevena™ Plus 125 Therapy Unit, when used with 3M™ Prevena™ Dressings (3M™ Prevena™ Plus Incision Management System), is intended to manage the environment of closed surgical incisions and surrounding intact skin in patients at risk for developing post-operative complications, such as infection, by maintaining a closed environment via the application of a negative pressure wound therapy system to the incision.

Prevena Dressing used with Prevena Therapy Units: PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units manage the environment of closed surgical incisions and remove fluid away from the surgical incision via the application of -125mmHg continuous negative pressure. When used with legally marketed compatible PREVENA™ dressings for up to seven days, PREVENA™ 125 and PREVENA PLUS™ 125 Therapy Units are intended to aid in reducing the incidence of seroma; and in patients at high risk for post-operative infections, aid in reducing the incidence of superficial surgical site infection in Class I and Class II wounds.

Limitations:

  • The device is not intended to treat surgical site infection or seroma.
  • Safety and effectiveness in pediatric population (<22 years old) have not been evaluated.
  • Safety and effectiveness in Class III (Contaminated) and Class IV (Dirty/Infected) wounds have not been demonstrated. Furthermore, Class IV surgical wounds are not expected to be closed primarily, and the subject device should only be used on closed surgical incisions.
  • The device has not been demonstrated to reduce deep incisional and organ space surgical site infections.
  • The device has not been demonstrated to be effective in reducing the incidence of surgical site infection and seroma in all surgical procedures and patient populations; therefore, the device may not be recommended for routine use to reduce the incidence of surgical site infection and seroma.
  • Please refer to the ‘Summary of Clinical Information’ section for the specific surgical procedures and patient populations included in the clinical studies. Surgeons should continue to follow the ‘Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection’2 and the ‘American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines’3 for best practices in preventing surgical site infection. US FDA Cleared: Dressings/ Systems (Prevena Dressings used with compatible Solventum NPWT units - ActiVAC, Ulta, and RX4) and applicable OUS countries that leverage US Indication: The PREVENA™, PREVENA PLUS™, PREVENA DUO™, and PREVENA RESTOR™ Incision Management Systems are intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudates via the application of negative pressure wound therapy.

References:

  1. Cooper HJ, Silverman RP, Collinsworth A, Bongards C, Griffin L. Closed Incision Negative Pressure Therapy vs Standard of Care Over Closed Knee and Hip Arthroplasty Surgical Incisions in the Reduction of Surgical Site Complications: A Systematic Review and Meta-analysis of Comparative Studies. Arthroplasty Today. 2023;21:101120. Published 2023 Apr 3. doi:10.1016/j.artd.2023.101120
  2. Berríos-Torres, S. I., Umscheid, C. A., Bratzler, D. W., Leas, B., Stone, E. C., Kelz, R. R., Reinke, C. E., Morgan, S., Solomkin, J. S., Mazuski, J. E., Dellinger, E. P., Itani, K. M., Berbari, E. F., Segreti, J., Parvizi, J., Blanchard, J., Allen, G., Kluytmans, J. A., Donlan, R., & Schecter, W. P. (2017). Centers for Disease Control and Prevention guideline for the prevention of surgical site infection, 2017. JAMA Surgery, 152(8), 784. https://doi.org/10.1001/jamasurg.2017.0904
  3. Ban, K. A., Minei, J. P., Laronga, C., Harbrecht, B. G., Jensen, E. H., Fry, D. E., Itani, K. M. F., Dellinger, P. E., Ko, C. Y., & Duane, T. M. (2017). American College of Surgeons and Surgical Infection Society: Surgical Site Infection Guidelines, 2016 update. Journal of the American College of Surgeons, 224(1), 59–74. https://doi.org/10.1016/j.jamcollsurg.2016.10.029